Neurology Segment Drives Embolization Plugs Market Growth
According to our new research study named "Embolization Plugs Market Forecast to 2031 – Global Analysis – by Application, End User, and Geography," the market was valued at US$ 315.24 million in 2024 and is projected to reach US$ 564.45 million by 2031; it is expected to register a CAGR of 8.8% during 2025–2031. Rising prevalence of vascular diseases, growing demand for minimally invasive procedures, and technological advancements in device design drive the adoption of embolization plugs. The integration of hybrid materials and smart technologies is projected to bring new embolization plugs market trends in the coming years.
Embolization plugs are minimally invasive devices that are placed in the blood vessels to close off abnormal or unwanted blood flow. They are used to treat aneurysms, arteriovenous malformations, tumors, and bleeding that is controlled by a local dressing made up of small blood vessels. The demand for minimally invasive procedures, the prevalence of vascular diseases, the technological advancement in the design of the plugs, the rising need for embolization due to cancer, and the increasing adoption of interventional radiology are driving the global embolization plugs market growth. Additionally, the improving healthcare sector and the wider clinical applications are also contributing to the rising embolization plugs market size.
Embolization Plugs Market, by Region, 2024 (%)
Embolization Plugs Market Trends & Key Opportunities 2031
Download Free SampleEmbolization Plugs Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Source: The Insight Partners Analysis
Embolization Plugs Market Analysis Based on Segmental Evaluation:
Based on application, the embolization plugs market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. The neurology segment held a significant embolization plugs market share in 2024. Embolization plugs are progressively being utilized in neurology to mend intricate cerebrovascular scenarios such as cerebral aneurysms, arteriovenous malformations (AVMs), and dural arteriovenous fistulas. Their accurate delivery and control make them a perfect match for the sensitive neurovascular anatomy. For example, the Amplatzer Vascular Plug can be guided through the highly twisted cerebral vessels to isolate aneurysm sacs, thus inducing thrombosis with little or no vessel trauma. The growth in this segment is mainly due to the increased incidence of neurovascular diseases, the improved neuroimaging techniques, and the shift to minimally invasive neurointerventional therapies. Moreover, because of technological innovations, embolization plugs are being designed for increased biocompatibility, better radiopacity, and accurate deployment through micro-catheters, which is a great advantage in the narrow and delicate vessels of the brain. These plugs provide the means for controlled occlusion, thus lessening the possibility of migration in high-flow cerebral lesions.
The geographical scope of the embolization plugs market report encompasses an assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America dominated the embolization plugs market share in 2024. The rising prevalence of heart diseases, cancer, and other chronic conditions has directly led to an upsurge in the demand for minimally invasive treatments, such as embolization procedures that use plugs for precise vessel occlusion. Technological and procedural developments in interventional radiology and the use of imaging technologies have made the interventions more accurate, thus increasing the confidence of the physicians and widening the possible clinical applications, thereby boosting the embolization plugs market growth.
Furthermore, the demand is propelled by the ever-increasing preference for minimally invasive procedures, which are characterized by shorter recovery times, reduced hospital stays, and lower rates of complications. A robust healthcare system and high healthcare expenditure in the US and Canada are the main factors for the quick uptake of innovative embolization products. In addition, good reimbursement policies for endovascular procedures attract more patients to the market by lowering their out-of-pocket expenses. The knowledge of the clinicians about the safety and efficacy of embolization plugs, as well as ongoing product innovation by the top medical device companies, drives the market growth. The availability of advanced embolization devices due to regulatory approvals also accelerates their clinical use.
Since 2005, radiologists have seen a 140% increase in embolization cases thanks to better screening in primary care using the ankle-brachial index and changes in guidelines that recommend early intervention. Innovations such as bioresorbable plugs that reduce recanalization and the growth of telemedicine after 2023 are continuously increasing the need; thus, embolization is becoming an indispensable vascular tool in the healthcare industry. Recent changes emphasize embolization's gradual transformation to a minimally invasive technique of patient care. Instylla, Inc. was granted FDA premarket approval for the Embrace Hydrogel Embolic System, a resorbable plug that enables the accurate occlusion of a peripheral vessel with a lowered risk of migration, which is great for PAD interventions, in August 2025. Varian's Embozene microspheres also got a CE Mark in September 2025 for genicular artery embolization (GAE) in knee osteoarthritis, going the application route to non-vascular areas. Liquid embolics such as n-BCA systems from CERENOVUS (Johnson & Johnson) introduced procedural kits in March 2024, to make aneurysm and AVM treatments better with the control of flow.
Medtronic Plc, Terumo Corp., INVAMED, Abbott Laboratories, Merit Medical Systems Inc, Lifetech Scientific Corp, Shape Memory Medical, and ArtVentive Medical Group are among the leading companies profiled in the embolization plugs market report.
Based on application, the embolization plugs market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. On the basis of end user, the market is classified into hospital, ambulatory centers, and others. Geographically, the embolization plugs market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com